BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
Abstract:
The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with an adrenergic receptor.
Public/Granted literature
Information query
Patent Agency Ranking
0/0